The latest Investing Matters Podcast episode with Inclusive Asset Management's Alexandra McGuigan has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAVGR.L Regulatory News (AVGR)

  • There is currently no data for AVGR

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Scheme Meeting Results

23 Oct 2015 15:29

RNS Number : 3013D
AvangardCo Investments Public Ltd
23 October 2015
 

 

NOT FOR DISTRIBUTION IN OR INTO OR TO ANY PERSON LOCATED OR RESIDENT IN THE UNITED STATES, ITS TERRITORIES AND POSSESSIONS OR TO ANY U.S. PERSON (AS DEFINED IN REGULATION S UNDER THE U.S. SECURITIES ACT OF 1933, AS AMENDED).

23 October 2015

Avangardco Investments Public Limited UK Scheme of Arrangement

 

Scheme Meeting Results

On 24 September 2015, the High Court of Justice in England and Wales (the "Court") ordered, amongst other things, that Avangardco Investments Public Limited (the "Company") be at liberty to convene a meeting of the Scheme Creditors to be held at 10.00 a.m. (London time) on 22 October 2015 at the offices of Latham & Watkins (London) LLP, 99 Bishopsgate, London, EC2M 3XF for the purpose of considering and, if thought fit, approving with or without modification, the scheme of arrangement (the "Scheme") proposed to be made between the Company and the Scheme Creditors (the "Scheme Meeting") in respect of its US$200 million 10.0% notes due 2015 (ISIN: XS0553088708) (the "Notes") issued under a trust deed dated 29 October 2010. Oleksiy Yergiyev of the Company was appointed to act as Chairman of the Scheme Meeting.

Where otherwise undefined, terms used in this press release shall have the meaning given to them in the explanatory statement which is available on the Scheme Website (the "Explanatory Statement"). 

As at 22 October 2015 following the close of the Scheme Meeting, Noteholders constituting 99.51% in number representing 99.89% in value of the Notes voted at the Scheme Meeting had validly voted in favour of the Scheme. Noteholders constituting 0.49% in number representing 0.11% in value of the Notes voted at the Scheme Meeting had voted against the Scheme. The Scheme was therefore approved by a majority in number representing more than 75% in value of creditors present and voting either in person or by proxy at the Scheme Meeting. Noteholders voting at the Scheme Meeting represented 89.20% of the outstanding principal amount of the Notes.

 

It will now be necessary for the Court to sanction the approved Scheme at a Court hearing to be held not before 2 p.m. on 26 October 2015 at the Rolls Building, Fetter Lane, London EC4A 1NL. All persons who were Scheme Creditors as at 20 October 2015 are entitled to attend the Court hearing in person or through counsel to support or oppose the sanctioning of the Scheme.

 

A further announcement surrounding the sanctioning of the Scheme will be made following the Court hearing. On the basis that the Scheme is sanctioned by the Court, we anticipate that the settlement date of the Scheme will be Wednesday 28 October 2015, with the unblocking of Notes to occur on this date.

 

For further information on the Scheme please contact UBS Limited or D.F. King Ltd.

 

UBS Limited as the Scheme Solicitation Agent

1 Finsbury Avenue

London EC2M 2PP

United Kingdom

 

Tel: +1-203-719-8682 / +44 20756 84601

E-mail: mark-t.watkins@ubs.com / torstein.berteig@ubs.com

Attention: Liability Management Group

 

D.F. King Ltd as the Information Agent

Email: avangard@dfkingltd.com

Website: http://sites.dfkingltd.com/avangard

 

 

In London:85 Gresham StreetLondon, EC2V 7NQUnited KingdomTelephone: +44 20 7920 9700

 

In Hong Kong:Suite 1601, 16/F, Central Tower28 Queen's Road CentralHong KongTelephone: +852 3953 7230

 

In New York:

48 Wall Street, 22nd Floor

New York, New York 10005

United States

Telephone: +1 212 269 5550

 

--------

 

This notice is neither an offer to purchase nor a solicitation of an offer to sell securities. The Scheme is not being made to any person in any jurisdiction in which the making of the Scheme would not be in compliance with the securities or other laws of such jurisdiction. The securities referred to herein have not been and will not be registered under the U.S. Securities Act of 1933, as amended (the "Securities Act"), and may not be offered or sold in the United States, unless registered under the Securities Act or unless an exemption from the registration requirements set forth in the Securities Act applies to them. No public offering of the securities will be made in the United States and the Company does not intend to make any such registration under the Securities Act.

 

In the United Kingdom, this communication is being distributed only to and is directed only at (a) persons who have professional experience in matters relating to investments falling within the definition of "investment professionals" in Article 19(5) of the Financial Services and Markets Act 2000 (Financial Promotion) Order 2005 (the "Order"), (b) high net worth entities falling within Article 49(2)(a) to (d) of the Order and (c) other persons to whom it may be lawfully communicated (all such persons together being referred to as "relevant persons"). Any person who is not a relevant person should not act or rely on this communication or any of its contents.

 

Statements contained herein may constitute "forward-looking statements". Forward-looking statements are generally identifiable by the use of the words "may", "will", "should", "aim", "plan", "expect", "anticipate", "estimate", "believe", "intend", "project", "goal" or "target" or the negative of these words or other variations on these words or comparable terminology.

 

Forward-looking statements involve a number of known and unknown risks, uncertainties and other factors that could cause the Company's or its industry's actual results, levels of activity, performance or achievements to be materially different from any future results, levels of activity, performance or achievements expressed or implied by such forward-looking statements. The Company does not undertake publicly to update or revise any forward-looking statement that may be made herein, whether as a result of new information, future events or otherwise.

 

No party accepts any responsibility or liability whatsoever for any loss or damage occasioned to any person arising out of the process described in this notice.

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
ROMBSBDGRDDBGUX
Date   Source Headline
3rd Dec 20214:40 pmRNSSecond Price Monitoring Extn
3rd Dec 20214:35 pmRNSPrice Monitoring Extension
18th Dec 202011:57 amRNSResult of AGM
20th Nov 20202:29 pmRNSNotice of AGM
4th Sep 202012:07 pmRNSSecond Price Monitoring Extn
4th Sep 202012:02 pmRNSPrice Monitoring Extension
8th Nov 20194:41 pmRNSSecond Price Monitoring Extn
8th Nov 20194:35 pmRNSPrice Monitoring Extension
8th Nov 201912:02 pmRNSPrice Monitoring Extension
18th Oct 20197:18 amRNSResult of AGM
20th Sep 20198:05 amRNSNotice of AGM
30th Aug 20197:00 amRNSHalf-year Report
26th Apr 20197:00 amRNSAnnual Financial Report
5th Apr 20197:00 amRNSFinal Results
6th Feb 20194:55 pmRNSDEBT RESTRUCTURING AGREEMENT WITH OSCHADBANK
29th Oct 20184:34 pmRNSPostponement Of Principal Redemption
26th Sep 201810:23 amRNSResults of AGM
31st Aug 201812:24 pmRNSAGM Notification
31st May 20187:00 amRNS1st Quarter Results
2nd May 20182:25 pmRNSAvangardco May 2018 Interest Payment
26th Apr 20187:00 amRNS2017 Annual Report Publication
29th Mar 20187:00 amRNSFinal Results
20th Feb 20189:52 amRNSEU APPROVAL TO EXPORT SHELL EGGS
30th Nov 20177:00 amRNS3rd Quarter Results
30th Oct 20179:08 amRNSOCTOBER 2017 INTEREST PAYMENT
9th Oct 20172:11 pmRNSResult of AGM
28th Sep 20171:02 pmRNSULF SEPTEMBER 2017 INTEREST PAYMENT
13th Sep 20172:51 pmRNSNotice of AGM
31st Aug 20177:00 amRNSHalf-year Report
17th Jul 201710:07 amRNSFinancial Advisor Appointment
31st May 20177:00 amRNS1st Quarter Results
2nd May 20172:07 pmRNSApril 2017 Interest Payment
26th Apr 20179:55 amRNSAnnual Financial Report
6th Apr 20173:45 pmRNSSecond Price Monitoring Extn
6th Apr 20173:40 pmRNSPrice Monitoring Extension
29th Mar 20177:00 amRNSFinal Results
22nd Mar 20171:43 pmRNSNotice of Results
21st Mar 20179:30 amRNSUKRLANDFARMING PLC MARCH 2017 INTEREST PAYMENT
17th Mar 20176:02 pmRNSCORRECTION: Comment on temporary ban on import
17th Mar 201710:25 amRNSComment on temporary ban on import from Ukraine
20th Dec 20163:45 pmRNSSecond Price Monitoring Extn
20th Dec 20163:40 pmRNSPrice Monitoring Extension
30th Nov 20167:00 amRNS3rd Quarter Results
25th Nov 201612:23 pmRNSNotice of Results
26th Sep 20163:45 pmRNSSecond Price Monitoring Extn
26th Sep 20163:40 pmRNSPrice Monitoring Extension
16th Sep 20162:19 pmRNSResults of AGM
6th Sep 20163:45 pmRNSSecond Price Monitoring Extn
6th Sep 20163:40 pmRNSPrice Monitoring Extension
31st Aug 20167:00 amRNSHalf Year Results

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.